Compare CRVS & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVS | EVLV |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 843.7M | 994.7M |
| IPO Year | 2016 | 2020 |
| Metric | CRVS | EVLV |
|---|---|---|
| Price | $10.60 | $4.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $31.50 | $9.85 |
| AVG Volume (30 Days) | 998.8K | ★ 2.1M |
| Earning Date | 11-05-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.04 | 41.18 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $145,905,000.00 |
| Revenue This Year | N/A | $25.01 |
| Revenue Next Year | N/A | $20.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.48 |
| 52 Week Low | $6.39 | $4.02 |
| 52 Week High | $26.95 | $7.48 |
| Indicator | CRVS | EVLV |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 47.16 |
| Support Level | $9.21 | N/A |
| Resistance Level | $10.81 | $5.86 |
| Average True Range (ATR) | 0.64 | 0.20 |
| MACD | 0.12 | 0.03 |
| Stochastic Oscillator | 73.19 | 49.32 |
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Evolv Technologies Holdings Inc is a security technology company pioneering Artificial Intelligence (AI)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. It serves customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. The company operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.